Trademark Search in Canada

UNISTAC

View On IC.GC.CA

REGISTERED

on 11 Apr 2024

Last Applicant/ Owned by

ONEGENE BIOTECHNOLOGY INC.

No 204, 2nd Floor, 91, Changnyong-daero,256beon-gil, Yeongtong-guSuwon-si Gyeonggi-do

Serial Number

2136981 filed on 6^th Aug 2021

Registration Number

TMA1228833 registered on 11^th Apr 2024

Registration expiry Date

6^th Aug 2031

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

UNISTAC

Trademark usage description

pharmaceutical products for the treatment of infectious diseases, namely, pneumonia, influenza, coronavirus, measles, hepatitis, chicken pox, meningoc Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of infectious diseases, namely, pneumonia, influenza, coronavirus, measles, hepatitis, chicken pox, meningococcal; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the prevention of diseases of the endocrine system, namely, growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of diseases of the endocrine system, namely, growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical agents, namely, enzyme inhibitors affecting metabolism; pharmaceutical preparations, namely, vaccines for human use for immunity adjustment; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases, namely, COVID-19, influenza, HIV, AIDS, meningitis, pneumonia, rotavirus, chicken pox; pharmaceutical preparations for treatment and prevention of urinary tract infections, bladder infections, kidney infections; pharmaceutical preparations for preventing and treating obesity; pharmaceutical preparations for the treatment of bone diseases, osteoporosis, osteopenia, bone cancer, paget's disease, osteogenesis imperfecta, ostenonecrosis, fibrous dysplasia; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antagonists for activating cellular function; pharmaceutical preparations for the treatment of digestive diseases; cardiovascular pharmaceutical preparations; cardiovascular treatment preparations; pharmaceutical preparations for the prevention of central nervous system [CNS] disorders; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the prevention of inflammatory disorders, namely, asthma, celiac disease, allergies, inflammatory bowel disease, transplant rejection, hepatitis, gout; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; synthetic peptides for pharmaceutical purposes; clinical medical reagents; clinical diagnostic reagents; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for use in tissue transplantation; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for tumor treatment; stimulants for the central nervous system; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, lupus, addison disease; pharmaceutical products for treating respiratory diseases.

Classification kind code

Class [042]
Technological studies in the field of pharmaceutical biotechnology; research and development of vaccines and medicines; research and development of technology in the field of pharmaceutical biotechnology; development in the field of pharmaceutical biotechnology; research in the field of pharmaceutical biotechnology; laboratory research in the field of biology; biological research services; development of biologics; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research in the field of pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; drug development; pharmaceutical research and development; research relating to pharmaceuticals; scientific research in the field of pharmacy; medical laboratory services; research relating to medical treatment; medical research laboratory services; scientific research for medical purposes; research and development of amino acid for medical purpose; research and development of peptide for medical purposes; research and development of technology for medicinal chemical manufacturing; medicine research; research relating to medical substances; medical research; research relating to chemistry.

Classification kind code

Mark Details

Serial Number

2136981

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 18^th May 2023	Agent Changed
Submitted for opposition 22 on 11^th Jan 2023	Search Recorded
Submitted for opposition 20 on 11^th Jan 2023	Examiner's First Report
Submitted for opposition 223 on 11^th Jan 2023	Total Provisional Refusal
Submitted for opposition 256 on 1^st Aug 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 30^th Sept 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 29^th Sept 2021	Created
Submitted for opposition 31 on 29^th Sept 2021	Formalized
Submitted for opposition 228 on 6^th Aug 2021	International Registration
Submitted for opposition 30 on 6^th Aug 2021	Filed